The non responders could have been more moderate stage of alzheimer's, I think it works better before the brain dies to far off. However they must have seen some response but at a slower rate if all the participants decided to keep taking the drug. I believe only mild alzheimer's candidates will be accepted into the trial.
News 
Market Data 
Discover 
